A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Clinical trial NCT03747653 · UNKNOWN
Trial details
- NCT number
- NCT03747653
- Sponsor
- Kaifeng Pharmaceutical (Group) Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-03-08
- Primary completion
- 2020-05-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.